Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
| 12/31/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | -362.75% | 83.17% | -1,136.34% | ||
| Total Depreciation and Amortization | -154.55% | 33.33% | -40.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 306.95% | -105.99% | 543.58% | ||
| Change in Net Operating Assets | -120.23% | -- | 1,820.00% | ||
| Cash from Operations | -10.29% | -39.38% | -83.50% | ||
| Capital Expenditure | 100.00% | -50.00% | 33.33% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 100.00% | -50.00% | -105.56% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 292.58% | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -100.00% | -- | -- | ||
| Cash from Financing | -25.21% | -- | -- | ||
| Foreign Exchange rate Adjustments | -144.00% | -159.57% | 242.42% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -372.83% | -55.44% | -71.87% | ||